300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Construction
Mobile
Oil and Gas
Marketplace
Retail
Film
Payments
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Puerto Rico
Oman
Poland
Guernsey
Cameroon
Colombia
Armenia
China
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
New Zealand
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Botswana
Moldova
Seychelles
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Estonia
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Liechtenstein
Iceland
Cambodia
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotech Startup Investors in Hong Kong (November 2026)

The most active venture capital funds and angel investors investing in Hong Kong Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Hong Kong Biotech startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Alibaba Entrepreneurs Fund
VC Fund
5 Hong Kong, Taiwan, United States Series A, Seed, Series B Artificial Intelligence, Software, E-Commerce $510k–$150M
Deep Knowledge Group
VC Fund
4 United Kingdom, United States, Hong Kong Seed, Convertible Note Health Care, Biotechnology, Market Research
Lever VC
VC Fund
4 United States, China, United Kingdom Seed, Series A, Pre-Seed Food and Beverage, Food Processing, Biotechnology $80k–$18M
Loyal VC
VC Fund
3 United States, Canada, United Kingdom Pre-Seed, Seed Software, Artificial Intelligence, E-Commerce $20k–$2.5M
Artesian VC
VC Fund
3 Australia, United States, China Seed, Pre-Seed, Venture - Series Unknown Software, Health Care, Artificial Intelligence $29k–$17M
Particle Accelerator Limited (ParticleX)
VC Fund
3 Hong Kong, United States, Taiwan Seed, Pre-Seed, Series A Artificial Intelligence, Software, Information Technology $430k–$11M
Whist Subholdings
VC Fund
2 United States Seed, Venture - Series Unknown Medical, Agriculture, Health Care
Gobi Partners
VC Fund
2 China, Hong Kong, Malaysia Venture - Series Unknown, Series A, Seed E-Commerce, Financial Services, Software $300k–$100M
PT Medion
VC Fund
2 United States Seed, Venture - Series Unknown Medical, Agriculture, Health Care
Simmons Foods
VC Fund
2 United States Seed, Venture - Series Unknown Medical, Agriculture, Health Care
Capital Union Investments
VC Fund
2 United States, Hong Kong Seed, Series A, Series B Health Care, Marketing, Personal Health $150k–$10M
Bold Capital Partners
VC Fund
2 United States, Hong Kong, India Series A, Series B, Seed Health Care, Software, Biotechnology $2M–$58M
StartUp Health
VC Fund
2 United States, Canada, United Kingdom Seed, Venture - Series Unknown, Pre-Seed Health Care, Medical, Wellness $20k–$15M
Arkansas Development Finance Authority
VC Fund
2 United States Venture - Series Unknown, Seed, Pre-Seed Medical, Biotechnology, Manufacturing $2M–$35M
CPT Capital
VC Fund
2 United States, Israel, United Kingdom Seed, Series A, Series B Food and Beverage, Biotechnology, Food Processing $1.3M–$226M
FHB Ventures
VC Fund
2 United States Seed, Series A, Series B Agriculture, AgTech, Medical
Coent Venture Partners
VC Fund
2 Japan, Taiwan, Hong Kong Seed, Angel, Series A Software, Information Technology, Education $275k–$10M
Gobi Partners GBA
VC Fund
2 China, Hong Kong Seed, Series A, Angel Biotechnology, Medical, Solar $1.4M–$13M
Innovation and Technology Venture Fund
VC Fund
2 Hong Kong, China, Singapore Series A, Seed, Series B Information Technology, Software, FinTech $250k–$150M
Garri Zmudze
Angel
2 United States, Hong Kong, Estonia Seed, Pre-Seed, Venture - Series Unknown Biotechnology, SaaS, Software $300k–$2.2M
WuXi AppTec
VC Fund
1 United States, China, Israel Series A, Series B, Series C Biotechnology, Health Care, Pharmaceutical $6M–$187M
Prox Ventures
VC Fund
1 China, United States, United Kingdom Seed, Series A Medical, Biotechnology, Health Care $2.5M–$30M
A-Level Capital
VC Fund
1 United States, Hong Kong Seed, Venture - Series Unknown, Series A Health Care, Medical, SaaS $100k–$6M
Formic Ventures
VC Fund
1 United States, United Kingdom, Hong Kong Seed, Series A, Venture - Series Unknown Biotechnology, Health Care, Pharmaceutical $958k–$61M
Hillhouse Investment
VC Fund
1 China, United States, Singapore Series B, Series A, Series C Biotechnology, Health Care, Software $2.9M–$230M
Apis Partners
VC Fund
1 India, Singapore, South Africa Private Equity, Series B, Series C Financial Services, FinTech, Payments $10M–$120M
AngelHub
VC Fund
1 Hong Kong, United States, Mexico Seed, Series A, Pre-Seed FinTech, Software, Blockchain $500k–$4.8M
Beyond Ventures
VC Fund
1 China, Hong Kong, Canada Seed, Series A, Angel Information Technology, Health Care, Artificial Intelligence $409k–$138M
James Mellon
Angel
1 United States, United Kingdom, Israel Series A, Seed Biotechnology, Food and Beverage, Food Processing $894k–$47M
Pavilion Capital
VC Fund
1 United States, Japan, Singapore Series B, Series A, Series C Biotechnology, Health Care, Information Technology $2M–$200M
Ping An
VC Fund
1 China, United States, Japan Series A, Series E, Angel Health Care, FinTech, Finance $425k–$300M
Human Longevity and Performance Impact Venture Fund
VC Fund
1 Hong Kong, United States Series A Health Care, Biotechnology, Artificial Intelligence
Vectr
VC Fund
1 United States, Hong Kong, Singapore Seed, Series A, Series B FinTech, Financial Services, Artificial Intelligence $547k–$70M
Emerging Technology Partners
VC Fund
1 United States, China, Hong Kong Series A, Series B, Seed Health Care, Biotechnology, Medical $1M–$40M
Venturra
VC Fund
1 Indonesia, Singapore, Vietnam Seed, Series A, Series B E-Commerce, Financial Services, Health Care $1.2M–$60M
FutureX Capital
VC Fund
1 China, United States, Hong Kong Seed, Series B, Series A Artificial Intelligence, Software, Health Care
ASBV
VC Fund
1 China, Australia, Hong Kong Seed, Series A, Angel Health Care, Medical, Biotechnology
Hillhouse Ventures
VC Fund
1 China, Singapore, Norway Series A, Series B, Seed Manufacturing, Biotechnology, Health Care
AEF Greater Bay Area Fund
VC Fund
1 Hong Kong, China, Macao Series A, Seed, Series B Artificial Intelligence, Life Science, Biotechnology $2.5M–$28M
Thia Ventures
VC Fund
1 United States, France, Denmark Series A, Seed, Pre-Seed Biotechnology, Health Care, Manufacturing $3.4M–$48M
Joel Neoh
Angel
1 Malaysia, Hong Kong, Singapore Seed, Angel, Pre-Seed E-Commerce, Apps, Mobile
ETP Ventures
VC Fund
1 China, Hong Kong, Switzerland Series A, Seed, Angel Health Care, Biotechnology, Medical
S2G Investments
VC Fund
1 United States, Canada, United Kingdom Series A, Series B, Venture - Series Unknown Food and Beverage, Agriculture, Biotechnology $3.9M–$100M
The International Medical
VC Fund
1 Hong Kong Seed Medical, Hospitality, Biotechnology
Juvenescence
VC Fund
1 United States, Hong Kong, Isle of Man Venture - Series Unknown, Series A, Seed Biotechnology, Pharmaceutical, Health Care $1.5M–$19M
Alon Capital Ltd
VC Fund
1 Hong Kong Series A, Series B Biopharma, Life Science, Biotechnology
LongeVC
VC Fund
1 United States, United Kingdom, Canada Seed, Series A, Venture - Series Unknown Health Care, Biotechnology, Therapeutics $1.3M–$94M
Markus Haefeli
Angel
1 Hong Kong Seed Biotechnology
Good Startup
VC Fund
1 United States, Canada, Israel Seed, Series A, Pre-Seed Food and Beverage, Biotechnology, Food Processing $1.2M–$12M
WI Harper Group
VC Fund
1 United States, Taiwan, China Series A, Seed, Series B Software, Health Care, Biotechnology $1.4M–$25M
Access all 157 investors in Hong Kong Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Alibaba Entrepreneurs Fund
VC Fund · Causeway Bay, Hong Kong Island, Hong Kong · 5 investments in Hong Kong Biotech startups

The Entrepreneurs Fund is a not-for-profit initiative launched by Alibaba Group in 2015 to help entrepreneurs and young graduates realize their dreams and vision. Two separate funds have been set up in Hong Kong and Taiwan respectively to support specific programs in each place.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, E-Commerce
  • Stage:Series A, Seed, Series B
  • Geography: Hong Kong, Taiwan, United States

Investor stats

  • Total investments: 82
  • Round size: Seed $510k–$8M; Series A $2M–$15M; Series B $7M–$150M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: May invest from a new fund soon — raised $130M in 2015

Portfolio highlights

  • Tiiny AI — Tiiny AI offers a ready-to-use open-source ecosystem with one-click installation for models.
  • Vpon Holdings — Vpon AI Big Data group helps companies discover opportunities with the power of data. Reliable Data, Smarter Analysis, Precise Planning for Measurable Results
  • Neolix — Neolix is a technologically innovative company that specializes in the production of physical and sports scenes. Neolithic Century Technology is an innovative design team. Committed to design research, industrial design, structural engineering, product customization, providing customers with creative value enhancement services. Service customersinclude Lenovo, Siemens, Midea, GE, State Grid, CSIC, Honeywell, Bank of China, Agricultural Bank, etc.
Show all investments...

Deep Knowledge Group
VC Fund · London, England, United Kingdom · 4 investments in Hong Kong Biotech startups

Deep Knowledge Group is a data-driven consortium of commercial and non-profit organizations active on many fronts in the realm of DeepTech and Frontier Technologies (AI, Longevity, BioTech, Pharma, FinTech, GovTech, SpaceTech, FemTech, Data Science, InvestTech), ranging from scientific research to investment, entrepreneurship, analytics, consulting, media, philanthropy and more. As a mathematical corporation focused on building the bridge to the 5th Industrial Revolution, Deep Knowledge Group is decisively committed to DeepTech for Social Good, Techno-Philanthropy and DeepTech and Longevity Industry Financial Commoditization (establishing the core investment and financial industry infrastructure needed for the emergence of DeepTech and Longevity as fundamentally new asset classes). Deep Knowledge Group has been committed since 2014 to the corporate thesis of DeepTech for social impact, techno-ethical business for social good, and the continual reinvestment of profits into the expansion of our core Data Science, AI and analytics assets and the refinement of our financial-ecosystemic development projects (which we see as the major tool driving our Group’s further growth as a Data Science driven financial corporation with focus on Longevity and DeepTech). Our unique approach lies in combining ecosystemic financial innovations with sophisticated AI and Data Science technology development for DeepTech and Longevity Industry analysis, benchmarking and forecasting. We remain committed as always to developing and deploying reliably sophisticated and multidimensional Big Data analytics and AI driven technological forecasting and benchmarking of DeepTech, Longevity and related industries, pioneering the fundamental tools required for strategic decision making in these unprecedentedly complex and innovation-driven sectors, laying the foundation and basis for defining, thinking about and understanding the coming DeepTech Revolution. However, more than this, the Group remains just as decisively committed to the practical execution of many of these forecasted developments by establishing the core investment and financial industry infrastructure (platforms, indices, exchanges, financial instruments and derivatives) needed for accelerated and de-risked DeepTech and Longevity Industrialization, and their emergence as fundamentally new asset classes.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Market Research
  • Stage:Seed, Convertible Note
  • Geography: United Kingdom, United States, Hong Kong

Investor stats

  • Total investments: 13
  • Lead/follow: 38% lead, 62% follow
  • Last fund: May invest from a new fund soon — raised $100M in 2015

Portfolio highlights

  • Longevity Card — Health is the New Wealth. Launching Soon.
  • Deep Pharma Intelligence — Deep Pharma Intelligence is a leading UK-based market intelligence agency focused on the emerging markets in the Pharmaceutical, Biotech, and Healthcare industries
  • DeepTech and Longevity Industry Financial Advisors — ongevity and DeepTech Financial Advisors Ltd. is a leading advisory boutique focused on the Longevity and DeepTech industries. Its shareholders and senior managers have built up significant expertise in private and public capital markets, as well as a substantial network of companies operating in the industry. They provide intermediary financialservices that are deployed in the form of an interactive online semi-automated IT-platform designed for end-users of investment products and services. They serve as the WealthTech/InvestTech financial marketplace for professional investors, family offices, and institutional investors and provide industry-specific analytical systems to enable the significant optimisation of dealflow, stock selection, and execution capabilities for investors.The company is decisively committed to establishing the core investment and financial industry infrastructure (platforms, indices, exchanges, financial instruments and derivatives) needed to execute the concept of DeepTech and Longevity Financial Commoditization, reflected in its pursuit of a truly ecosystemic approach through its various financial service divisions to establish an integral financial infrastructure to support the commoditization of the DeepTech and Longevity Industries as fundamentally new asset classes.
Show all investments...

Lever VC
VC Fund · New York, New York, United States · 4 investments in Hong Kong Biotech startups

Lever VC is a U.S.-Hong Kong venture capital fund founded by Managing Partner Nick Cooney and investing in early stage companies in the alternative protein sector (plant-based and “clean”/cell-based meat, egg and dairy companies). Lever VC operates globally, with offices in Hong Kong and the U.S. and staff in the US, Hong Kong, Europe, andIsrael. Entrepreneurs and startups interested in connecting with Lever VC about possible investment can reach the team and submit information about their company at http://www.levervc.com.Managing Partner Nick Cooney is the Co-Founder and former Managing Trustee of New Crop Capital, a private venture capital trust vehicle investing in the alternative protein space, and is Co-Founder of the Good Food Institute, the world’s largest non-governmental organization working to grow the alternative protein space. The General Partners at Lever VC have deployed over $1.5 billion in capital over the past decade across a variety of sectors, including over thirty deals in the alternative protein space.

Show more...

Investment focus

  • Industry: Food and Beverage, Food Processing, Biotechnology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, China, United Kingdom

Investor stats

  • Total investments: 60
  • Round size: Seed $700k–$8.1M; Pre-Seed $80k–$850k; Series A $1.9M–$18M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: Likely actively investing — fresh fund, raised $50M in 2025

Portfolio highlights

  • Omni — Omni provides Healthy Vegan Dog Food in the UK, made by vets to be a nutritionally complete meal for your dog. Feed your dog all the goodness of plants backed by science.
  • Peppertux — Peppertux is the modern pistachio company bringing pistachios out of the shell and into everything we love. Discover pistachio spreads, sauces, and snacks, we make playful, crave-worthy products that celebrate pistachios in their most delicious forms... because pistachios deserve better!
  • ns/tx industries — ns/tx industries is a food manufacturing and technology company that processes and sells fish and meat products.
Show all investments...

Loyal VC
VC Fund · Toronto, Ontario, Canada · 3 investments in Hong Kong Biotech startups

Loyal runs a global venture fund with quarterly redemptions and a proprietary gate-stage process, reducing investment bias and unlocking greater returns. Partnered with INSEAD, Founder Institute, and 500+ advisors, we are Loyal to the world with 250+ investments in 50+ countries.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, E-Commerce
  • Stage:Pre-Seed, Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 195
  • Round size: Seed $142k–$2.5M; Pre-Seed $20k–$1.2M
  • Lead/follow: 13% lead, 87% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Dehurdle — Practice high-stakes conversations with real-time AI. Instant speaking pace and competency feedback. No voice recordings are kept after the session.
  • Amplicity — Amplicity retrofits backup batteries and UPS systems to cut peak charges, earn from energy markets and keep backup ready, with no upfront capital.
  • Vireo Capital — Vireo provides software for deal diligence, fund administration, and portfolio monitoring at private market investment firms.
Show all investments...

Artesian VC
VC Fund · Melbourne, Victoria, Australia · 3 investments in Hong Kong Biotech startups

Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004, Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: Australia, United States, China

Investor stats

  • Total investments: 659
  • Round size: Seed $40k–$4M; Pre-Seed $29k–$535k; Venture - Series Unknown $650k–$17M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: Likely still investing — raised $36M in 2023

Portfolio highlights

  • Vaulta — Vaulta is a battery casing technology company based in Brisbane, Australia. Using advanced composite materials and smart, streamlined design, Vaulta has developed a lighter and smaller battery case with fewer parts, creating scalable efficiencies and opportunities for manufacturers. Vaulta founder and director Dominic Spooner has over 12 yearsexperience as a design engineer, and has worked in a range of industries, including renewables and batteries, defence and aerospace, consumer products, commercial products and startups. While working in battery design, Dominic saw firsthand that opportunities for growth were being overlooked in favour of continuing with the status quo – and that’s when the idea for Vaulta was born.Vaulta’s world-first no-weld design means modules can be easily assembled and disassembled, cells reused and recycled, and new cells added as battery technology continues to evolve.From stationary storage and electric vehicles to defence, aerospace and beyond, Vaulta’s battery case technology works wherever batteries do.
  • Coherence Neuro — Opto Biosystems specializes in the development of innovative healthcare technologies that bridge the gap between cancer neuroscience and bioelectronics. The company focuses on creating smaller, softer, and wireless biological interfaces designed to offer a new treatment modality. By leveraging advancements in neural engineering and bioelectronics,Opto Biosystems is dedicated to building new tools that interface with the body, aiming to improve patient outcomes in the healthcare sector. Their work includes exploring the stability of thin-film electrodes for neuromodulation, highlighting their commitment to advancing medical technology.
  • Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
Show all investments...

Particle Accelerator Limited (ParticleX)
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 3 investments in Hong Kong Biotech startups

Particle Accelerator Limited (ParticleX) was founded in late 2017 by Shine Works. ParticleX is a tech-based startup investor and accelerator based in Hong Kong. ParticleX combines network, capital and research resources, accelerating the pace of innovative technology and helping the early-stage startups to win cross-border opportunities acrossAsia.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Hong Kong, United States, Taiwan

Investor stats

  • Total investments: 30
  • Round size: Seed $1.2M–$5.5M; Pre-Seed $430k–$1.6M; Series A $1M–$11M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • KorrAI — KorrAI helps you analyze rapidly evolving geospatial data and accelerate mineral exploration timelines.
  • MediConCen — MediConCen is a medical network that mobilize medical experts all over the world to serve the insured population without middleman. They revolutionize the current medical network with Blockchain technology. MediConCen liberalizes the existing heavily walled medical network with the use of Blockchain technology, allowing individual clinics to rejointhe insurance market with a one-stop solution. The next generation medical ecosystem starts right here.MediConCen aims to integrate all clinics, insured employees and business entities into a unified Blockchain ecosystem, making business truly efficient, transparent and trustworthy.
  • Ephod Technology — Ephod Intelligence is fund managers' research copilot, offering investment hypothesis validation, and personalized trading signals to empower fundamental research.
Show all investments...

Whist Subholdings
VC Fund · 2 investments in Hong Kong Biotech startups

Whist Subholdings is a venture capital investment firm.

Show more...

Investment focus

  • Industry: Medical, Agriculture, Health Care
  • Stage:Seed, Venture - Series Unknown
  • Geography: United States

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
Show all investments...

Gobi Partners
VC Fund · Kuala Lumpur, Kuala Lumpur, Malaysia · 2 investments in Hong Kong Biotech startups

Gobi Partners is an Asia-focused VC backing early to growth stage startups. US$1.6B AUM, 400+ companies, 75 exits. Strategic guidance, founder network available.

Show more...

Investment focus

  • Industry: E-Commerce, Financial Services, Software
  • Stage:Venture - Series Unknown, Series A, Seed
  • Geography: China, Hong Kong, Malaysia

Investor stats

  • Total investments: 436
  • Round size: Seed $300k–$8M; Series A $1.6M–$16M; Venture - Series Unknown $1.1M–$100M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely still investing — raised $1.3B in 2023

Portfolio highlights

  • Yuan Planet — Youdi is a second-hand auto parts trading platform.
  • Camera360 — Camera360 is a mobile photo editing and selfie camera app that offers filters, beautification, and creative effects. It uses AI-based features like face detection, skin smoothing, beautification, and auto-enhancement to improve photos. The app also includes AI-powered effects such as makeup filters, portrait retouching, and scene optimization for images.
  • nanoSkunkWorkx — nanoSkunkWorkX develops nanotechnology for AGI scaling and allergy biosensing.
Show all investments...

PT Medion
VC Fund · 2 investments in Hong Kong Biotech startups

PT Medion is a venture capital investment firm.

Show more...

Investment focus

  • Industry: Medical, Agriculture, Health Care
  • Stage:Seed, Venture - Series Unknown
  • Geography: United States

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
Show all investments...

Simmons Foods
VC Fund · Siloam Springs, Arkansas, United States · 2 investments in Hong Kong Biotech startups

Simmons Foods is a leading supplier of poultry, pet and ingredient products based in Siloam Springs, Arkansas.

Show more...

Investment focus

  • Industry: Medical, Agriculture, Health Care
  • Stage:Seed, Venture - Series Unknown
  • Geography: United States

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Capital Union Investments
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 2 investments in Hong Kong Biotech startups

Capital Union Investments is a leader in private investment for early stage, growth, mezzanine, and pre-IPO capital. Headquartered in Hong Kong; and with offices in China and the US, the Firm's investment philosophy has been to create value by identifying leaders and innovators, whose businesses that can be developed in Asia. Our approach of providing unique investment insights, local knowledge and value-added operating capabilities, differentiates us from many traditional private investment funds.

Show more...

Investment focus

  • Industry: Health Care, Marketing, Personal Health
  • Stage:Seed, Series A, Series B
  • Geography: United States, Hong Kong

Investor stats

  • Total investments: 10
  • Round size: Seed $150k–$10M; Series A $2.7M–$10M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Moocho — About Moocho:Created by members of StubHub’s founding team, Moocho is the leading college rewards and payment app. With Moocho, college students pay with their phone at all their favorite merchants on and around campus and earn exclusive rewards and discounts for doing so. Moocho partners directly with universities to provide their studentswith an innovative product and acts as the de facto college marketing arm of its merchant partners, helping them drive more business and understand their customers better.Moocho is based in The LAB, the entrepreneurial hub of Miami’s Wynwood neighborhood. Moocho's management team has a track record of local, entrepreneurial E-commerce success, delivering relevant content to college students, managing large distributed campus operations, and running several rapid-growth, profitable companies. Read more about Moocho here: www.moocho.com
  • Surkus — Surkus is a product discovery app where DTC businesses can source feedback and content creation from consumers by offering free or heavily discounted products.
  • Dash Living — Dash Living is Asia's flexible living provider in Hong Kong, Singapore, and Japan. Furnished apartments, serviced apartments, hotels, and coliving spaces with all-inclusive rates for monthly & nightly stays.
Show all investments...

Bold Capital Partners
VC Fund · Santa Monica, California, United States · 2 investments in Hong Kong Biotech startups

A collection of entrepreneurs, engineers, physicists, doctors, surfers, and musicians who are committed to helping entrepreneurs achieve their dreams of changing the world.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: United States, Hong Kong, India

Investor stats

  • Total investments: 131
  • Round size: Seed $2M–$15M; Series A $6M–$40M; Series B $15M–$58M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • Evergreen — Omeat is real, lip-smacking meat, grown from cells, outside the animal. No sacrifice required.
  • KeyCare — KeyCare is a virtual care platform powered by Epic that was created to assist forward-thinking health systems in increasing patient access and quality by enhancing the alternatives available for virtual care.
  • General Compute — General Compute provides an ASIC-based cloud inference platform focused on running AI inference workloads. The company offers an OpenAI-compatible API that allows users to access hosted large language models and switch from existing GPU-based providers by changing the base URL and API key. It supports deploying both its own supported models andcustomer-supplied models on its infrastructure, emphasizing high token throughput and low time to first token. General Compute also offers dedicated custom deployments with service-level agreements, custom scaling, and guaranteed capacity for production workloads. Its infrastructure targets use cases such as AI agents, coding assistants, and real-time voice applications that require low-latency, high-throughput inference.
Show all investments...

StartUp Health
VC Fund · New York, New York, United States · 2 investments in Hong Kong Biotech startups

Organizing and investing in a global army of entrepreneurs committed to achieving health moonshots

Show more...

Investment focus

  • Industry: Health Care, Medical, Wellness
  • Stage:Seed, Venture - Series Unknown, Pre-Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 407
  • Round size: Seed $100k–$3.5M; Pre-Seed $20k–$854k; Venture - Series Unknown $150k–$15M
  • Lead/follow: 3% lead, 97% follow
  • Last fund: May invest from a new fund soon — raised $31M in 2018

Portfolio highlights

  • AvoMD — AvoMD is reimagining clinical decision support with interactive point-of-care software, available standalone and via EHR integrations, and seamless content building tools.
  • Hidoc Consult — Hidoc Consult: Boost your well-being with free consultations, 24/7 access to quality healthcare, complete privacy, user-friendly, and a trusted network of HCPs
  • NEXT Life Sciences — NEXT Life Sciences is developing the revolutionary Plan A™ procedure to bring the only scientifically proven technology in the category - Vasalgel® - to market.
Show all investments...

Arkansas Development Finance Authority
VC Fund · Little Rock, Arkansas, United States · 2 investments in Hong Kong Biotech startups

Welcome to Arkansas Development Finance Authority (ADFA), your source for safe, decent, affordable housing in Arkansas. Contact us at (501) 682-5900 to secure your dream home today!

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Manufacturing
  • Stage:Venture - Series Unknown, Seed, Pre-Seed
  • Geography: United States

Investor stats

  • Total investments: 6
  • Round size: Venture - Series Unknown $2M–$35M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
  • BlueOak Resources — BlueOak: Sourcing Metals Sustainably™ from End-of-Life Electronics.BlueOak believes in the philosophy of resource and capital efficiency. They are building distributed mini-refineries that use proven, capital-efficient refining processes towards extracting precious metals and rare earth elements from e-waste. Their vision is to revolutionize howwe treat end of life electronics: converting the e-waste of today into a sustainable source of critical metals and rare earths for the technologies of tomorrow.
  • United States Steel — U. S. Steel Home Page
Show all investments...

CPT Capital
VC Fund · London, England, United Kingdom · 2 investments in Hong Kong Biotech startups

Investing in the Future of Protein.We invest in visionary founders creating the future of food and materials.

Show more...

Investment focus

  • Industry: Food and Beverage, Biotechnology, Food Processing
  • Stage:Seed, Series A, Series B
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 63
  • Round size: Seed $1.3M–$7M; Series A $6M–$50M; Series B $16M–$226M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Shiru — Discover Shiru. We are an Ingredient Company that Identifies and Creates Functional Ingredients for the Plant-Based Industry.
  • Xias Bio — Mitigate risk with flexible licensing options. Partner with us to transform your ideas into high-performance innovations optimized for efficacy and differentiation.
  • Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
Show all investments...

FHB Ventures
VC Fund · 2 investments in Hong Kong Biotech startups

FHB Ventures is a venture capital firm.

Show more...

Investment focus

  • Industry: Agriculture, AgTech, Medical
  • Stage:Seed, Series A, Series B
  • Geography: United States

Investor stats

  • Total investments: 4
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • EarthOptics — GroundTruth Ag is a soil cloud creator specializing in sustainable agricultural management. GroundTruth offers insights into soil management and health as well as near-real-time actionable data layers that cover the physical, chemical, and biological characteristics of the soil. This technology allows farmers to obtain accurate soil informationwhile also offering carbon creditors low-cost, hyper-accurate verification.
  • Pacific GeneTech — Pacific GeneTech Improving human life through biotech and animal health solutions
Show all investments...

Coent Venture Partners
VC Fund · Singapore, Central Region, Singapore · 2 investments in Hong Kong Biotech startups

Coent Venture Partners provides seed and venture-stage funding to brilliant entrepreneurs and companies across all sectors in Asia. The company backed these entrepreneurs and companies with unparalleled support in funding, management, overseas business development, and exposure to their network.

Show more...

Investment focus

  • Industry: Software, Information Technology, Education
  • Stage:Seed, Angel, Series A
  • Geography: Japan, Taiwan, Hong Kong

Investor stats

  • Total investments: 11
  • Round size: Seed $275k–$1.2M; Series A $2.7M–$10M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — raised $10M in 2014

Portfolio highlights

  • Flyspaces — FlySpaces empowers businesses as a digital marketplace that provides short-term work and meeting space solutions to entrepreneurs, start-ups, SMEs and mobile professionals. Whether the need is for an hour, a day, a week or a few months - we have a network of hundreds of spaces to discover across key South East Asian cities.For venue owners,FlySpaces acts as a digital marketing platform that connects you to a vast user base, allowing you to optimize and monetize your space.We recognize that workspace is more than a mere location. It is a setting that inspires ideas, motivates action and promotes growth. With FlySpaces, find where your business will accomplish its next milestone.FlySpaces empowers businesses as a digital marketplace that provides short-term work and meeting space solutions to entrepreneurs, start-ups, SMEs and mobile professionals. Whether the need is for an hour, a day, a week or a few months - we have a network of hundreds of spaces to discover across key South East Asian cities.For venue owners, FlySpaces acts as a digital marketing platform that connects you to a vast user base, allowing you to optimize and monetize your space.We recognize that workspace is more than a mere location. It is a setting that inspires ideas, motivates action and promotes growth. With FlySpaces, find where your business will accomplish its next milestone.
  • Prenetics — CircleDNA is an at-home, non-invasive DNA test providing health insights across 500+ reports based on your unique genetic blueprint.
  • HelloWings — "See" the cheapest fare, year-round and fees included. Customized combination tickets. HelloWings ensures you'll arrive to destination on budget & in style.
Show all investments...

Gobi Partners GBA
VC Fund · Central and Western, Hong Kong Island, Hong Kong · 2 investments in Hong Kong Biotech startups

Gobi Partners is an Asia-focused VC backing early to growth stage startups. US$1.6B AUM, 400+ companies, 75 exits. Strategic guidance, founder network available.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Solar
  • Stage:Seed, Series A, Angel
  • Geography: China, Hong Kong

Investor stats

  • Total investments: 7
  • Round size: Seed $2M–$13M; Series A $1.4M–$12M
  • Lead/follow: 57% lead, 43% follow

Portfolio highlights

  • GenEditBio — GenEditBio is a biotech company that specializes in providing curative gene editing based solutions for genetic diseases.
  • Immuno Cure — Immuno Cure, it is a biotechnology company it is specialized in the study and creation of immunotherapies for cancer, inflammatory, and infectious disorders.
  • Luquos Energy — Luquos Energy is a renewable energy company that offers energy consulting and management services.
Show all investments...

Innovation and Technology Venture Fund
VC Fund · 2 investments in Hong Kong Biotech startups

The HK$2 billion ITVF was set up by the Hong Kong Government with a view to creating a vibrant local innovation and technology eco-systems

Show more...

Investment focus

  • Industry: Information Technology, Software, FinTech
  • Stage:Series A, Seed, Series B
  • Geography: Hong Kong, China, Singapore

Investor stats

  • Total investments: 45
  • Round size: Seed $250k–$90M; Series A $500k–$15M; Series B $1M–$150M
  • Lead/follow: 0% lead, 100% follow
  • Last fund: May invest from a new fund soon — raised $256M in 2017

Portfolio highlights

  • Varadise — Varadise is a digital twin platform offering technology services, cloud platforms, and business services comprising IoT and AI.
  • LeapXpert — LeapXpert delivers business communication governance and compliance with a platform that ensures secure, compliant messaging across multiple channels.
  • Cornerstone Robotics — Cornerstone Robotics operates to improve the accessibility of high-end medical services in China.
Show all investments...

Garri Zmudze
Angel · , , Switzerland · 2 investments in Hong Kong Biotech startups

Garri is a seasoned business angel with an extensive track record in tech business and an early investor in science-intensive ventures, such as Insilico Medicine, Basepaws, Deep Longevity. Prior to founding LongeVC, he co-founded Longenesis — a medical technology startup company working towards providing a technological bridge between Healthcare institutions and the BioTech industry with an aim to help identify and unlock the hidden value of biomedical data to accelerate the novel drug and treatment discovery and provide better help to those in need. In 2021, Garri became Director of the Board at Longevity Science Foundation — a Swiss and USA based non-profit organisation advancing human longevity by funding research and development of medical technologies to extend the healthy human lifespan.

Show more...

Investment focus

  • Industry: Biotechnology, SaaS, Software
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: United States, Hong Kong, Estonia

Investor stats

  • Total investments: 9
  • Round size: Seed $300k–$2.2M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • PickMyBrain — Digital brains of real people. Ask theirs anything. Build yours, and it answers for you day and night.
  • Longenesis — Promoting collaboration between biomedical institutions, patient organizations and research partners by identifying biomedical data from metadata files, by onboarding population cohorts and by engaging new patients in the research.
  • Profi — The Only Comprehensive Platform for Care Delivery & Coaching. Enabling health and wellness providers deliver outstanding programs, collaborative care and member experience, all within one modern platform.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
WuXi AppTec
VC Fund · Shanghai, Shanghai, China · 1 investments in Hong Kong Biotech startups

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve the productivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Series B, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 49
  • Round size: Series A $6M–$90M; Series B $21M–$130M; Series C $30M–$187M
  • Lead/follow: 20% lead, 80% follow
  • Last fund: May invest from a new fund soon — raised $250M in 2015

Portfolio highlights

  • D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
  • ShouTi — ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
  • Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
Show all investments...

Prox Ventures
VC Fund · Shanghai, Shanghai, China · 1 investments in Hong Kong Biotech startups

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential. They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many years of remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: China, United States, United Kingdom

Investor stats

  • Total investments: 84
  • Round size: Seed $2.5M–$30M; Series A $3M–$28M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • BCI-Sonics — BCI-Sonics is an innovative medtech company developing non-invasive brain-computer interface solutions using advanced transcranial focused ultrasound (tFUS) technology. The company builds a next-generation therapeutic platform enabling precise neuromodulation to treat central nervous system disorders. BCI-Sonics develops low-intensity focusedultrasound technology that non-invasively stimulates deep brain regions with high precision. They combine ultrasound engineering and neuroscience to interface safely and effectively with the human brain without surgery. The company is creating an AI ultrasound brain-computer interface platform for therapeutic neuromodulation applications.
  • Fengxun Biotech — Nantong Fengxun Bio is a medical testing service provider. Its primary business focus is on testing services, cell technology research and development, and human stem cell technology development and application, among other things.
  • Kingsung Medical Group — Kingsung Medical Group operates under the Mission “Simplify Surgery, Beautiful Life,” with its innovation centered on four core technology platforms at its Tianjin base: Mechanical Design, Polymer Materials, Biodegradable Magnesium Alloys, and Collagen Biomaterials. These platforms have enabled the development of pioneering medical devices,including microvascular anastomosis devices and neural tube. In particular, the Group’s biodegradable magnesium alloy technology is spearheading the advancement of next-generation orthopedic implants. Kingsung’s technological capabilities are evidenced by a portfolio of over 190 patents and its recognition as a National Key Enterprise. The Group also actively contributes to the industry as a standing council member of the Microsurgery Branch of the China Association of Medical Devices Industry and a member of the Chinese Society for Biomaterials.
Show all investments...

A-Level Capital
VC Fund · Baltimore, Maryland, United States · 1 investments in Hong Kong Biotech startups

Founded in 2015, A-Level Capital is a student-run venture capital firm that aims to empower Johns Hopkins University's entrepreneurial community through funding and support.

Show more...

Investment focus

  • Industry: Health Care, Medical, SaaS
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: United States, Hong Kong

Investor stats

  • Total investments: 19
  • Round size: Seed $100k–$4.6M; Series A $2.8M–$6M; Venture - Series Unknown $320k–$500k
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Order — Modernize your procure-to-pay process with Order.co. Automate purchasing & payments to help your business save time, save money, and gain clarity.
  • Siren Care — Siren Socks help reduce the risk of foot ulcers for patients with diabetes through the early detection of potential injuries.
  • Leap AI — Make films, images, voices and designs with Seedance 2.5, Veo 3.1, Kling 3.0, Nano Banana Pro, GPT Image 2, FLUX.2 and more, from one-click recipes or a blank prompt. Make anything you can imagine, in one creative studio.
Show all investments...

Formic Ventures
VC Fund · San Francisco, California, United States · 1 investments in Hong Kong Biotech startups

Formic Ventures is a diversified venture capital firm that makes early-stage investments in biotechnology startups focused on human longevity as well as technology startups and companies that make human lives more meaningful.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: United States, United Kingdom, Hong Kong

Investor stats

  • Total investments: 48
  • Round size: Seed $958k–$9M; Series A $17M–$61M; Venture - Series Unknown $2.4M–$3.1M
  • Lead/follow: 2% lead, 98% follow

Portfolio highlights

  • SonoThera — Explore therapeutic ultrasound for non-invasive, targeted genetic medicine delivery that improves precision and biodistribution. Learn more.
  • cheMastery — Echo handles repetitive tasks with accuracy and precision, allowing your chemists to tackle high-value challenges.
  • Biogenesis — Clinical research platform tailored towards industry sponsors, clinical research sites & patients
Show all investments...

Hillhouse Investment
VC Fund · Changyang, Beijing, China · 1 investments in Hong Kong Biotech startups

Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 331
  • Round size: Series A $2.9M–$165M; Series B $15M–$230M; Series C $15M–$220M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: May invest from a new fund soon — raised $11B in 2018

Portfolio highlights

  • Sainte — Sainte is a company which provides professional nutritional solutions for babies with different nutritional needs
  • Vita Dynamics — Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently.
  • NeueHCT — Horizon Continental Technology is a joint venture between Continental Group and Horizon Robotics
Show all investments...

Apis Partners
VC Fund · London, England, United Kingdom · 1 investments in Hong Kong Biotech startups, 11 in the past 12 months

Apis Partners LLP backs growth financial services innovators who create transformative impact in their communities.

Show more...

Investment focus

  • Industry: Financial Services, FinTech, Payments
  • Stage:Private Equity, Series B, Series C
  • Geography: India, Singapore, South Africa

Investor stats

  • Total investments: 79
  • Round size: Series B $10M–$110M; Series C $45M–$78M; Private Equity $10M–$120M
  • Lead/follow: 67% lead, 33% follow
  • Last fund: Likely actively investing — fund raised in 2026

Portfolio highlights

  • BIPO — Streamline your global workforce with BIPO's award-winning HR solutions. HRMS, payroll outsourcing & EOR services across 170+ countries. Get a free demo today!
  • Moneybox — Moneybox is the simple way to save, invest, buy your first home, and combine your old pensions - all with one award-winning app. Download now.
  • Paymentology — Paymentology's card issuing & processing platform helps banks & Fintechs to launch innovative, secure, and flexible card payment products in weeks.
Show all investments...

AngelHub
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 1 investments in Hong Kong Biotech startups

Join the movement toward democratised private markets, where investing is open to everyone. Discover a range of vetted tech investments, embodying the spirit of innovation in Web3, FinTech, AI, and ESG. Transform your investment strategy for a smarter, more sustainable future.

Show more...

Investment focus

  • Industry: FinTech, Software, Blockchain
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Hong Kong, United States, Mexico

Investor stats

  • Total investments: 24
  • Round size: Seed $1.1M–$4.8M; Pre-Seed $500k–$2.3M; Series A $3M–$4M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Pitz — PITZ is building the infrastructure layer for the $1T global auto repair industry — starting with Latin America, expanding to the US in Q4 2026. The platform combines voice-driven AI diagnostics, automated parts procurement, and embedded financing into a single system of record for independent repair shops. In 9 months: $1.78M ARR, 1,462 activeworkshops across Mexico and Brazil, 83% gross margin, 70% subscription revenue, and NRR above 100%. Founded in 2025. Delaware C-Corp. Seed stage.
  • Antiverse — Designing biologics for 100 challenging targets
  • Nufi — Nufi is Latin America's first alternative identity bureau, empowering businesses with fast, reliable, and AI-powered verification solutions. Our platform offers Know Your Business (KYB) and Know Your Customer (KYC) services, enabling the instant verification of individuals and companies in less than 5 minutes. By providing clean, structureddata through seamless API integrations, Nufi helps financial institutions, fintechs, proptechs, and HR companies make secure, data-driven decisions. With access to over 130 data sources, Nufi stands out for its speed, accuracy, and scalability, driving trust and transparency across the region's transactions.
Show all investments...

Beyond Ventures
VC Fund · Tsuen Wan, New Territories, Hong Kong · 1 investments in Hong Kong Biotech startups

A US$60M startup fund aiming at revitalizing HK’s ecosystem of innovation by connecting local venture capitalists and entrepreneurs to invest in ideas and startups. It is co-founded by Hony Capital, eGarden Ventures & several successful HK entrepreneur

Show more...

Investment focus

  • Industry: Information Technology, Health Care, Artificial Intelligence
  • Stage:Seed, Series A, Angel
  • Geography: China, Hong Kong, Canada

Investor stats

  • Total investments: 24
  • Round size: Seed $720k–$3M; Angel $409k–$14M; Series A $1.6M–$138M
  • Lead/follow: 58% lead, 42% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Chaomu Technology — Chaomu Technology is a high-tech research and development enterprise dedicated to solving difficult human eye diseases. The company provides medical intelligent high-tech equipment and solutions. The pursuit of super purpose is to alleviate the increasing sub-light suffering of eye disease patients worldwide in a more scientific manner and torealize the dream of returning hundreds of millions of eye disease patients to a bright world.
  • YAS — YAS turns live machine data into a risk score fleet operators and insurers can act on in real time, across EV fleets, autonomous vehicles, and robotics.
  • GOGO Digital Innovation — GOGO Digital Innovation is a trendy digital asset art collection platform.
Show all investments...

James Mellon
Angel · San José, Islas Baleares, Spain · 1 investments in Hong Kong Biotech startups

James Mellon is based out of San José, Islas Baleares, and is the co-founder and chairman of Juvenescence. James previously worked at Griffin Thornton as a trainee fund manager. James Mellon attended the University of Oxford.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Food Processing
  • Stage:Series A, Seed
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 35
  • Round size: Seed $894k–$20M; Series A $3M–$47M
  • Lead/follow: 46% lead, 54% follow

Portfolio highlights

  • Callers AI — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
  • Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
  • The Duppy Share — The Duppy Share is a new Caribbean “quirky” golden rum from the islands of Barbados and Jamaica.
Show all investments...

Pavilion Capital
VC Fund · New York, New York, United States · 1 investments in Hong Kong Biotech startups

Provides growth equity to market leading companies in the United States and China

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Information Technology
  • Stage:Series B, Series A, Series C
  • Geography: United States, Japan, Singapore

Investor stats

  • Total investments: 75
  • Round size: Series A $2M–$67M; Series B $17M–$140M; Series C $35M–$200M
  • Lead/follow: 19% lead, 81% follow
  • Last fund: May invest from a new fund soon — raised $50M in 2018

Portfolio highlights

  • Rebellions — Drive AI Innovation. Simple. Fast. At Scale.
  • Lhoopa — Making homeownership achievable for every Filipino family.
  • Fleet Space Technologies — Fleet is an agile, next generation connectivity company. Our mission is to Connect Everything using cutting-edge communications and space technologies to maximise the resource efficiency of human civilisation and enable the next industrial revolution with our free, ubiquitous connectivity platform.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Ping An
VC Fund · Shenzhen, Guangdong, China · 1 investments in Hong Kong Biotech startups

Ping An Insurance (Group) Company of China, Ltd. ("Ping An" or the “Company” or the “Group") was established in 1988 in Shekou, Shenzhen. The Group is the first insurance company in China to adopt a shareholding structure. Today, it has developed into a personal integrated financial services group with three core businesses of insurance, banking and investment, enjoying parallel growth of its traditional and non-traditional financial businesses. The Group’s shares are listed on the Hong Kong Stock Exchange (stock code: 2318) and on the Shanghai Stock Exchange (stock code: 601318). Ping An’s vision is to become China’s leading personal integrated financial services provider, establishing a traditional business framework supported by the Group’s three pillars of business, namely insurance, banking and investment, and continuing to promote the parallel growth of its traditional and non-traditional financial businesses. For the traditional business, Ping An will focus on building up the financial supermarket and promoting customer migration. For the non-traditional business, the Group will strive for innovation by weaving financial services into the very fabric of everyday life: health, food, housing, transportation and entertainment, establish the integrated financial services platform of “One Customer, One Account, Multiple Products, and One-Stop Services”, deliver customers a brand experience of “Expertise makes life easier”, achieve sustainable growth in profits, and provide long-term and stable returns to shareholders.

Show more...

Investment focus

  • Industry: Health Care, FinTech, Finance
  • Stage:Series A, Series E, Angel
  • Geography: China, United States, Japan

Investor stats

  • Total investments: 30
  • Round size: Angel $425k–$3.8M; Series A $1.5M–$300M; Series E $7.7M–$200M
  • Lead/follow: 53% lead, 47% follow
  • Last fund: Likely still investing — raised $850M in 2024

Portfolio highlights

  • Lixiangjia — The professional global Chinese overseas asset reconfiguration consulting service platform is dedicated to providing one-stop overseas asset product information support services for Chinese wealth management practitioners. It has set up branches in many cities across the country to provide institutions, financial planners and medium and high networth families. Professional overseas asset reconfiguration plan.
  • Biren Technology — Biren Technology is a high-tech startup that has the niche in softwares, hardwares, and chip system.The niche software department is led by the industry's top talents, composed of field technical experts and software elite engineers. The niche hardware department is committed to building a wide range of computing solutions based on generalcomputing, combining versatility and specificity.As a frontier research department of the niches, the Institute aims to study the key technologies of new intelligent computing systems, focusing on new architectures and advanced compilation technologies.
  • Hangzhou Yingde Gas — Hangzhou Yingde Gas is a company that specializes in the manufacturing and sales of industrial automatic control system devices and electrical signal equipment.
Show all investments...

Human Longevity and Performance Impact Venture Fund
VC Fund · 1 investments in Hong Kong Biotech startups

Human Longevity and Performance Impact Venture Fund is a longevity focused early-stage venture capital fund dedicated to providing resources, insight, and leadership to companies whose mission is to improve human health and drive longevity through technology, predictive analytics, research, and patient care. HLPIVF is establishing a synergisticecosystem of longevity and performance-focused companies to dramatically increase the volume and effectiveness of life-affirming diagnostics and therapeutics.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Artificial Intelligence
  • Stage:Series A
  • Geography: Hong Kong, United States

Investor stats

  • Total investments: 2
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Huma.AI — Qoniq combines tailored AI systems with expert guidance to help organizations transform large volumes of fragmented information into novel insight and defensible scientific understanding.
  • Deep Longevity — Deep Longevity provides customers with the most efficient, reliable, and useful aging and longevity clocks to address their needs.
Show all investments...

Vectr
VC Fund · Sheung Wan, Hong Kong Island, Hong Kong · 1 investments in Hong Kong Biotech startups

Vectr is a venture firm based in Hong Kong. They combine investment, creation and growth to deliver game-changing impact to teams ready to tackle global issues, transform industries and improve the lives of millions.That combines capital, creation and partnership to deliver game-changing impact. We strive to be the ideal partner for founders that are building transformation products and looking to expand their businesses into asia.

Show more...

Investment focus

  • Industry: FinTech, Financial Services, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, Hong Kong, Singapore

Investor stats

  • Total investments: 81
  • Round size: Seed $547k–$6.5M; Series A $1M–$37M; Series B $12M–$70M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Airstack — Every day there are millions of blockchain transactions. Airstack makes sense of them.
  • Micro Connect — Micro Connect provides market infrastructure, fintech, and platform development.
  • MasterExchange — Trading platform for music rights leveraging emerging technology to create friction free and compliant investment opportunities to everyone.
Show all investments...

Emerging Technology Partners
VC Fund · San Francisco, California, United States · 1 investments in Hong Kong Biotech startups

Founded in 2000, Emerging Technology Partners (“ETP”) is a life sciences focused investment fund with a cross border investment focus. ETP was founded with a simple mission: to provide capital and assist management in building and commercializing breakthrough diagnostic and therapeutic products in the fields of life sciences, while providingsuperior returns to their investors.ETP supports their portfolio companies facilitate strategic alliances including cross-border partnerships, recruit management, and acquire new products and technologies to accelerate growth in both US and China. They have investment partners in San Francisco, Boston, Washington DC, and Beijing.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Seed
  • Geography: United States, China, Hong Kong

Investor stats

  • Total investments: 17
  • Round size: Seed $1M–$3.5M; Series A $8.3M–$30M; Series B $3.4M–$40M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • Human Longevity — Human Longevity (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine. Its business areas include the HLI Health Nucleus, a genomicpowered clinical research center that uses whole-genome sequence analysis, advanced clinical imaging, and innovative machine learning, along with curated personal health information to deliver the most complete picture of individual health; HLIQ Whole Genome and HLIQ Oncology. It was founded in 2013 and is headquartered in San Diego, California.
  • CASI Pharmaceuticals — CASI is a NASDAQ-listed biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products.
  • Qiu Shui Semiconductor — Qiu Shui Semiconductor is a semiconductor company that specialized on Micro-LED display technology.Qiu Shui Semiconductor's core products are Micro-LED micro display chips and modules, which are widely utilized in digital car lighting, micro projection, and augmented reality displays.
Show all investments...

Venturra
VC Fund · Jakarta, Jakarta Raya, Indonesia · 1 investments in Hong Kong Biotech startups

Empowering outstanding entrepreneurs across Southeast Asia in creating the next defining technology companies.

Show more...

Investment focus

  • Industry: E-Commerce, Financial Services, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: Indonesia, Singapore, Vietnam

Investor stats

  • Total investments: 74
  • Round size: Seed $1.2M–$6M; Series A $4M–$12M; Series B $4M–$60M
  • Lead/follow: 20% lead, 80% follow
  • Last fund: May invest from a new fund soon — raised $150M in 2015

Portfolio highlights

  • FR8Labs — FR8Labs offers a practical freight forwarder solution that includes all of the modules required, without the extraneous trappings of overly sophisticated features that may not use but wind up paying for.
  • Saladin — Saladin is an online platform that provides life, health, automotive, and travel insurance services.
  • Klinik Pintar — Klinik Pintar membantu pasien mendapatkan layanan kesehatan primer terbaik di klinik, rumah, dan kantor.
Show all investments...

FutureX Capital
VC Fund · Central, Hong Kong Island, Hong Kong · 1 investments in Hong Kong Biotech startups

FutureX Capital is an investment firm.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Seed, Series B, Series A
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 25
  • Lead/follow: no public data

Portfolio highlights

  • Gewu Technology — Gewu Technology is an innovative IoT technology company, likely plays a role in building a future smart home by developing and integrating smart hardware and software solution
  • Lymow Technology — Lymow Technology is a manufacturer of lawn mowing robots.
  • Touchable Future — Touchable Future is an intelligent hardware company focusing on interactive innovation, committed to analyzing and customizing entertaining and emotional experiences for adults.
Show all investments...

ASBV
VC Fund · Shenzhen, Guangdong, China · 1 investments in Hong Kong Biotech startups

ASBV focuses on early and mid-term venture capital investments.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Angel
  • Geography: China, Australia, Hong Kong

Investor stats

  • Total investments: 27
  • Lead/follow: no public data

Portfolio highlights

  • Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
  • Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
  • Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.
Show all investments...

Hillhouse Ventures
VC Fund · Singapore, Central Region, Singapore · 1 investments in Hong Kong Biotech startups

Hillhouse Venture Capital is an investment institution established by Hillhouse Capital that focuses on investing in early-stage startups.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: China, Singapore, Norway

Investor stats

  • Total investments: 69
  • Lead/follow: no public data

Portfolio highlights

  • RoboticPlus.AI — RoboticPlus.AI is an robtics company that helps in architectural tech by providing intelligent robotic products for the construction sector.
  • HEMO BIOENGINEERING — HEMO BIOENGINEERING develops and provides innovative interventional medical devices to patients.
  • Hecheng New Materials Technology — Hecheng New Materials Technology is a manufacturing company offering bearing electrical corrosion and electrical insulation solutions.
Show all investments...

AEF Greater Bay Area Fund
VC Fund · Beijing, Beijing, China · 1 investments in Hong Kong Biotech startups

Gobi Partners is an Asia-focused VC backing early to growth stage startups. US$1.6B AUM, 400+ companies, 75 exits. Strategic guidance, founder network available.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Life Science, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: Hong Kong, China, Macao

Investor stats

  • Total investments: 15
  • Round size: Seed $2.5M–$5.1M; Series A $7M–$19M; Series B $14M–$28M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • SleekFlow — SleekFlow makes customer messaging apps such as WhatsApp and Facebook connected to one platform for teams to better support and engage customers.
  • Sandwich — Sandwich is an online platform that provides real-time trend analysis tools for developing ad campaigns and creating Meta Ads plans.
  • Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
Show all investments...

Thia Ventures
VC Fund · Genève, Geneve, Switzerland · 1 investments in Hong Kong Biotech startups

WE ARE AN EARLY-STAGE INVESTOR IN ONE OF THE MOST DYNAMIC AND ESSENTIAL FIELDS OF CURRENT HUMAN ENDEAVOR WE BRING ROBUST INVESTOR MUSCLE TO EARLY-STAGE VENTURES INVESTOR A specialized and focused investor Resources Powerful industry, substance and business resources Experience Wide networks and longstanding experience Team Yet, adaptability and speed of a lean, self-financed team

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Manufacturing
  • Stage:Series A, Seed, Pre-Seed
  • Geography: United States, France, Denmark

Investor stats

  • Total investments: 22
  • Round size: Seed $3.4M–$20M; Series A $6.8M–$48M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • EvodiaBio — EvodiaBio is a bio-industrial firm that creates natural, sustainable scents for the food and beverage industries. Founded in 2021 and is based in Copenhagen, Capital Region.
  • uFraction8 — Multi-award-winning, innovative, microfluidics-based filter systems to provide bio-manufacturers with energy-efficient & ultra-scalable bioprocessing systems.
  • Switch Bioworks — Switch Bioworks engineers symbiotic microbes to produce sustainable nitrogen fertilizer under the control of precise genetic circuits.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Joel Neoh
Angel · Kuala Lumpur, Kuala Lumpur, Malaysia · 1 investments in Hong Kong Biotech startups

Joel Neoh is the Founder and CEO of Fave. He attended Monash University.

Show more...

Investment focus

  • Industry: E-Commerce, Apps, Mobile
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Malaysia, Hong Kong, Singapore

Investor stats

  • Total investments: 9
  • Lead/follow: 44% lead, 56% follow

Portfolio highlights

  • Ejen2u — Platform Sistem Pengurusan Ejen paling Komprehensif
  • Evo — Social Commerce Software
  • ULive — ULive software automates orders from recording to managing orders from Facebook comments and allowing live sellers to perform essential functions such as product listings, inventory management, payments, and analytics. Currently we have users across Malaysia, Singapore, China, Laos and US.
Show all investments...

ETP Ventures
VC Fund · 1 investments in Hong Kong Biotech startups

ETP Ventures

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Seed, Angel
  • Geography: China, Hong Kong, Switzerland

Investor stats

  • Total investments: 4
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • SEIMEI — SEIMEI is a nutrition and anti-aging biotechnology brand.
  • Dima Biotech — DIMA uses HEK293 mammalian cell expression system to produce many druggable proteins especially membrane proteins. This will not only ensure the authentic
  • Deep Longevity — Deep Longevity provides customers with the most efficient, reliable, and useful aging and longevity clocks to address their needs.
Show all investments...

S2G Investments
VC Fund · Chicago, Illinois, United States · 1 investments in Hong Kong Biotech startups, 18 in the past 12 months

S2G Ventures is is a multi-stage venture fund investing in food and agriculture. We're harnessing the power of food innovation to create better outcomes for people and the planet.

Show more...

Investment focus

  • Industry: Food and Beverage, Agriculture, Biotechnology
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 232
  • Round size: Series A $4M–$55M; Series B $3.9M–$100M; Venture - Series Unknown $4.3M–$100M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: Likely actively investing — fresh fund, raised $1B in 2026

Portfolio highlights

  • Formic Technologies — At Formic, we want to increase the collective output of humanity by making automation deployments trivial and easy. Every factory should have access to unlimited 'labor' through robotics and automation rentals. We are building technology, financing, operations and services to make this vision possible.Formic is a fast-growingventure-backed startup focused on unlocking robotic automation in labor-starved industries such as food and beverage, advanced manufacturing, consumer packaged goods and other industrial settings. We combine financial innovation with a firm understanding of what robotics are capable of, to enable manufacturing customers to scale up their manufacturing capacity quickly and with minimal risk.
  • 3C Datalec — 3C Datalec refers to a newly formed entity created through a merger between 3C and Datalec Precision Installations
  • Wilde Brands — Thin and crispy, flavorful, and 7x the protein of a potato chip. Wilde Chips are grain & gluten free, Paleo certified, Keto friendly, non-GMO & allergen-free.
Show all investments...

The International Medical
VC Fund · Yau Tsim Mong, Kowloon, Hong Kong · 1 investments in Hong Kong Biotech startups

The International Medical is an investment firm

Show more...

Investment focus

  • Industry: Medical, Hospitality, Biotechnology
  • Stage:Seed
  • Geography: Hong Kong

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • BioMed Technology Holdings — BioMed develops a personalized intestinal treatment plan with probiotics, a series of probiotic products for adults and children, to solve problems such as moisture sensitivity, detoxification, weight loss, emotional stress, etc., recommend the best adult and children probiotics for you, buy now!
Show all investments...

Juvenescence
VC Fund · Douglas, NA - Isle of Man, Isle of Man · 1 investments in Hong Kong Biotech startups

We extend healthy lifespan through developing innovative medicines that target core aging mechanisms to not only treat but prevent age-related diseases.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Health Care
  • Stage:Venture - Series Unknown, Series A, Seed
  • Geography: United States, Hong Kong, Isle of Man

Investor stats

  • Total investments: 17
  • Round size: Series A $3M–$19M; Venture - Series Unknown $1.5M–$10M
  • Lead/follow: 47% lead, 53% follow

Portfolio highlights

  • LyGenesis — LyGenesis is an organ regeneration company enabling a patient's own lymph nodes to be used as bioreactors to regrow functioning ectopic organs. Their initial target organ for clinical development is liver regeneration, with a focus on helping patients with end stage liver disease (ESLD).
  • Morphoceuticals — Reprogramming the Software of Life: Understanding the bioelectric network that controls tissue repair and organ regeneration
  • MDI Therapeutics — MDI Therapeutics is an operator of a discovery stage company focused on developing novel therapies for fibrotic diseases. The company have developed a proprietary discovery platform which has successfully identified novel small molecule and protein drug candidates, and have advanced these programs through key translational experiments usingclinical biomarkers.
Show all investments...

Alon Capital Ltd
VC Fund · Rosh Ha'ayin, HaMerkaz, Israel · 1 investments in Hong Kong Biotech startups

Make the right startup move by using our startup tools, guides, calculators and templates. Learn from other successful entrepreneurs by reading our case studies

Show more...

Investment focus

  • Industry: Biopharma, Life Science, Biotechnology
  • Stage:Series A, Series B
  • Geography: Hong Kong

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Great Bay Bio — Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages.
Show all investments...

LongeVC
VC Fund · Lugano, Ticino, Switzerland · 1 investments in Hong Kong Biotech startups

With more than 30 portfolio companies across AI, pet health, ageing medicine and more, LongeVC provides venture capital for the biotech and longevity sectors.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Therapeutics
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 22
  • Round size: Seed $1.3M–$12M; Series A $17M–$94M
  • Lead/follow: 23% lead, 77% follow

Portfolio highlights

  • Trogenix — Trogenix operates as a therapeutics company, that treats aggressive cancers.
  • Constructive Bio — Constructive Bio designs and manufactures new-to-nature chemistries for next-generation therapies and materials.
  • Valink Therapeutics — Valink is developing a series of novel therapeutics that are more effective at attacking tumours, while sparing healthy tissue.
Show all investments...

Markus Haefeli
Angel · London, England, United Kingdom · 1 investments in Hong Kong Biotech startups

Markus Haefeli is Chairman of PTG Food and Regal Springs.

Show more...

Investment focus

  • Industry: Biotechnology
  • Stage:Seed
  • Geography: Hong Kong

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Avant Meats — They focus on technology, commercial product innovation, and branding as well as intellectual property portfolio building in the area of ‘cell-based’ animal protein food products.
Show all investments...

Good Startup
VC Fund · Singapore, Central Region, Singapore · 1 investments in Hong Kong Biotech startups

Good Startup exists to remove animals from the food system.

Show more...

Investment focus

  • Industry: Food and Beverage, Biotechnology, Food Processing
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 19
  • Round size: Seed $1.2M–$12M; Series A $6M–$12M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: Likely still investing — raised $34M in 2022

Portfolio highlights

  • ns/tx industries — ns/tx industries is a food manufacturing and technology company that processes and sells fish and meat products.
  • StrainX Bioworks —
  • Standing Ovation — Animal-free dairy cheese
Show all investments...

WI Harper Group
VC Fund · San Francisco, California, United States · 1 investments in Hong Kong Biotech startups

WI Harper Group is a venture capital firm that focuses on early and early expansion investments in Mainland China, Taiwan and Silicon Valley. It was founded in 1993. Made 300+ investments with 80+ exits. Manages 9 funds and over $1B in capital through 19 dedicated investment professionals located in Beijing, Taipei and San Francisco. The firm's focus is technology, clean technology and healthcare. Its track record includes [DivX](http://www.crunchbase.com/organization/divx), Focus Media, Vizio, SiRF and Commerce One.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: United States, Taiwan, China

Investor stats

  • Total investments: 170
  • Round size: Seed $1.4M–$5M; Series A $2M–$15M; Series B $6M–$25M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: May invest from a new fund soon — raised $174M in 2016

Portfolio highlights

  • Ainekko — Developer of an open-source AI computing infrastructure designed for building composable, low power systems. The company's platform offers modular tools for inference, hardware integration, and deployment, enabling the AI development market to experiment with, contribute to, and adopt flexible alternatives to proprietary black-box systemsthrough a collaborative, community-driven ecosystem that supports transparency, customization, and long-term maintainability.
  • Xsensio — Xsensio develops the unique Lab-on-Skin™​ sensing platform to sense in real-time biochemical information at the surface of the skin, providing unprecedented real-time information about our health and wellness, in a simple and non-invasive way.The Xsensio Lab-on-Skin™ sensing chip relies on a unique, highly-miniaturized sensing platform developedat the Nanolab of the Swiss Federal Institute of Technology. By leveraging semiconductor properties, our sensing platform unleashes a whole new set of possibilities in continuous health monitoring.
  • AdMaster — AdMaster (AdMaster精硕科技) is focused on domestic advertising, and is a third party provider of solutions for marketing massive data in China. It is also the key domestic independent third party of massive data management platform at present. AdMaster aims at helping advertisers to realize the monitoring and optimization of digital marketing effect aswell as improving the overall marketing ROI by technology-driven massive data perception research. AdMaster has a server cluster which processes more than 200 billion data and iterates more than 100 types of data models every month. The main research and service areas include digital marketing effect monitoring and researche, valuation and management of social media marketing effect, analysis and management of social big data, and more.
Show all investments...

Biotech Investor funding in Hong Kong at a glance

Stats across 78 deals from 157 investors.

157
investors
in Hong Kong Biotech startups
78
deals
in Hong Kong Biotech startups
$12M
median round
in Hong Kong Biotech startups
31%
lead investors
lead at least one round
21%
Seed
most common funding stage
93/7
VC / Angel
share of investor count

Access all 157 investors in Hong Kong Biotech startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech Investors in Hong Kong investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 157 investors investing in Hong Kong Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists